Acute disseminated encephalomyelitis post-SARS-COV-2 vaccination with Chadox1 nCov-19 (AZD1222) – A rare case report

Authors

  • Meghna Sivji
  • Vidya MV
  • Thara Pratap
  • Muhammed Jasim Abdul Jalal Consultant, Department of Internal Medicine and Rheumatology, VPS Lakeshore Hospital, Kochi, India

DOI:

https://doi.org/10.32677/ejms.v7i2.3365

Keywords:

ADEM, Vaccine Adverse Events, SARS COV 2 vaccination, ChAdOx1 n cov-19 (AZD1222), Covishield, SARS COV 2 infection, SARS COV 2 virus, Covid-19 infection

Abstract

Background: Acute disseminated encephalomyelitis (ADEM) is an inflammatory demyelinating disease of the CNS, characterized by fulminant multifocal neurologic injury and distinct neuropathologic findings.

Case Report: We report a case of a forty-nine-year-old female who presented with progressive weakness of right side of the body of one-week duration. Clinical, laboratory and radiological features favored demyelination. There was temporal association with taking SARS COV 2 vaccination (ChAdOx1 n cov -19 (AZD1222)). She was treated with a course of steroids and made a good recovery.

Conclusion: To our knowledge this is a rare case of ADEM noticed after ChAdOx1 nCoV-19 vaccine (AZD1222).

Published

2022-07-23

How to Cite

Sivji, M., MV, V., Pratap, T., & Abdul Jalal, M. J. (2022). Acute disseminated encephalomyelitis post-SARS-COV-2 vaccination with Chadox1 nCov-19 (AZD1222) – A rare case report. Eastern Journal of Medical Sciences, 7(2), 47-50. https://doi.org/10.32677/ejms.v7i2.3365

Issue

Section

Case Report